Aileens Pharma is an Italian biotech company that develops topical non-pharmacological and non-steroidal treatment for skin diseases. The company intends to use the funds to accelerate the development of its platform of topical non-steroidal treatments for atopic dermatitis both in children and adults, as well as other types of dermatological disorders. Its mission is to provide the first safe and effective topical treatment for skin diseases that does not cause the common side effects of medications that are currently available on the market.
Health Care, Pharmaceutical, skin care
Between €2.5 million-5 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Ailees Pharma? We’re happy to assist you with our Startup Sourcing service.